Rhone Ma Holdings Bhd - Asset Resilience Ratio
Rhone Ma Holdings Bhd (5278) has an Asset Resilience Ratio of 0.11% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2025)
This chart shows how Rhone Ma Holdings Bhd's Asset Resilience Ratio has changed over time. Check Rhone Ma Holdings Bhd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Rhone Ma Holdings Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Rhone Ma Holdings Bhd (5278) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 0% |
| Short-term Investments | RM292.65K | 0.11% |
| Total Liquid Assets | RM292.65K | 0.11% |
Asset Resilience Insights
- Limited Liquidity: Rhone Ma Holdings Bhd maintains only 0.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Rhone Ma Holdings Bhd Industry Peers by Asset Resilience Ratio
Compare Rhone Ma Holdings Bhd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
Drug Manufacturers - Specialty & Generic | 5.92% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 4.31% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401 |
Drug Manufacturers - Specialty & Generic | 5.09% |
|
KPC Pharmaceuticals Inc
SHG:600422 |
Drug Manufacturers - Specialty & Generic | 16.37% |
Annual Asset Resilience Ratio for Rhone Ma Holdings Bhd (2020–2025)
The table below shows the annual Asset Resilience Ratio data for Rhone Ma Holdings Bhd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.11% | RM292.65K ≈ $73.48K |
RM258.49 Million ≈ $64.90 Million |
-0.01pp |
| 2024-12-31 | 0.13% | RM282.85K ≈ $71.01K |
RM225.45 Million ≈ $56.60 Million |
+0.01pp |
| 2023-12-31 | 0.12% | RM273.04K ≈ $68.55K |
RM230.59 Million ≈ $57.89 Million |
-1.05pp |
| 2022-12-31 | 1.17% | RM2.56 Million ≈ $643.31K |
RM219.43 Million ≈ $55.09 Million |
-1.17pp |
| 2021-12-31 | 2.34% | RM4.58 Million ≈ $1.15 Million |
RM195.81 Million ≈ $49.16 Million |
-0.08pp |
| 2020-12-31 | 2.42% | RM4.51 Million ≈ $1.13 Million |
RM185.99 Million ≈ $46.70 Million |
-- |
About Rhone Ma Holdings Bhd
Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory servic… Read more